Cargando…
Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma
Merkel cell carcinoma (MCC) is a highly aggressive skin cancer with an increasing incidence. The understanding of the molecular carcinogenesis of MCC is limited. Here, we scrutinized the PI3K/AKT pathway, one of the major pathways activated in human cancer, in MCC. Immunohistochemical analysis of 41...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281946/ https://www.ncbi.nlm.nih.gov/pubmed/22363598 http://dx.doi.org/10.1371/journal.pone.0031255 |
_version_ | 1782224022274048000 |
---|---|
author | Hafner, Christian Houben, Roland Baeurle, Anne Ritter, Cathrin Schrama, David Landthaler, Michael Becker, Juergen C. |
author_facet | Hafner, Christian Houben, Roland Baeurle, Anne Ritter, Cathrin Schrama, David Landthaler, Michael Becker, Juergen C. |
author_sort | Hafner, Christian |
collection | PubMed |
description | Merkel cell carcinoma (MCC) is a highly aggressive skin cancer with an increasing incidence. The understanding of the molecular carcinogenesis of MCC is limited. Here, we scrutinized the PI3K/AKT pathway, one of the major pathways activated in human cancer, in MCC. Immunohistochemical analysis of 41 tumor tissues and 9 MCC cell lines revealed high levels of AKT phosphorylation at threonine 308 in 88% of samples. Notably, the AKT phosphorylation was not correlated with the presence or absence of the Merkel cell polyoma virus (MCV). Accordingly, knock-down of the large and small T antigen by shRNA in MCV positive MCC cells did not affect phosphorylation of AKT. We also analyzed 46 MCC samples for activating PIK3CA and AKT1 mutations. Oncogenic PIK3CA mutations were found in 2/46 (4%) MCCs whereas mutations in exon 4 of AKT1 were absent. MCC cell lines demonstrated a high sensitivity towards the PI3K inhibitor LY-294002. This finding together with our observation that the PI3K/AKT pathway is activated in the majority of human MCCs identifies PI3K/AKT as a potential new therapeutic target for MCC patients. |
format | Online Article Text |
id | pubmed-3281946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-32819462012-02-23 Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma Hafner, Christian Houben, Roland Baeurle, Anne Ritter, Cathrin Schrama, David Landthaler, Michael Becker, Juergen C. PLoS One Research Article Merkel cell carcinoma (MCC) is a highly aggressive skin cancer with an increasing incidence. The understanding of the molecular carcinogenesis of MCC is limited. Here, we scrutinized the PI3K/AKT pathway, one of the major pathways activated in human cancer, in MCC. Immunohistochemical analysis of 41 tumor tissues and 9 MCC cell lines revealed high levels of AKT phosphorylation at threonine 308 in 88% of samples. Notably, the AKT phosphorylation was not correlated with the presence or absence of the Merkel cell polyoma virus (MCV). Accordingly, knock-down of the large and small T antigen by shRNA in MCV positive MCC cells did not affect phosphorylation of AKT. We also analyzed 46 MCC samples for activating PIK3CA and AKT1 mutations. Oncogenic PIK3CA mutations were found in 2/46 (4%) MCCs whereas mutations in exon 4 of AKT1 were absent. MCC cell lines demonstrated a high sensitivity towards the PI3K inhibitor LY-294002. This finding together with our observation that the PI3K/AKT pathway is activated in the majority of human MCCs identifies PI3K/AKT as a potential new therapeutic target for MCC patients. Public Library of Science 2012-02-17 /pmc/articles/PMC3281946/ /pubmed/22363598 http://dx.doi.org/10.1371/journal.pone.0031255 Text en Hafner et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Hafner, Christian Houben, Roland Baeurle, Anne Ritter, Cathrin Schrama, David Landthaler, Michael Becker, Juergen C. Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma |
title | Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma |
title_full | Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma |
title_fullStr | Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma |
title_full_unstemmed | Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma |
title_short | Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma |
title_sort | activation of the pi3k/akt pathway in merkel cell carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281946/ https://www.ncbi.nlm.nih.gov/pubmed/22363598 http://dx.doi.org/10.1371/journal.pone.0031255 |
work_keys_str_mv | AT hafnerchristian activationofthepi3kaktpathwayinmerkelcellcarcinoma AT houbenroland activationofthepi3kaktpathwayinmerkelcellcarcinoma AT baeurleanne activationofthepi3kaktpathwayinmerkelcellcarcinoma AT rittercathrin activationofthepi3kaktpathwayinmerkelcellcarcinoma AT schramadavid activationofthepi3kaktpathwayinmerkelcellcarcinoma AT landthalermichael activationofthepi3kaktpathwayinmerkelcellcarcinoma AT beckerjuergenc activationofthepi3kaktpathwayinmerkelcellcarcinoma |